Results 71 to 80 of about 112,704 (293)
Molecular Diversity of BoNT-Producing Clostridia—A Still-Emerging and Challenging Problem
Diversity, 2023 The diversity of BoNT-producing Clostridia is still a worrying problem for specialists who explore the evolutionary and taxonomic diversity of C. botulinum.
Tomasz Grenda +6 more
doaj +1 more source
Headache and botulinum toxin [PDF]
The Journal of Headache and Pain, 2005 The authors discuss clinical and international experience about botulinum toxins (BTX types A and B) in headache treatment. Data from literature suggest good results for the treatment of tension-type headache, migraine and chronic tension-type headache. In the present paper mechanisms of action and injection sites will also be discussed.
Porta, M., Camerlingo, M.
openaire +2 more sources
Uso da toxina botulínica no controle do bruxismo [PDF]
, 2014 TCC (graduação) - Universidade Federal de Santa Catarina. Centro de Ciências da Saúde. Odontologia.A toxina botulínica é uma substância produzida pela bactéria Clostridium botulinum, e o seu uso oferece ao cirurgião dentista uma nova alternativa para ...
Francescon, Ariane
core
Microbial communities and functional diversity in seafood
JSFA reports, EarlyView.Abstract Functional diversity encompasses ecosystem processes that enhance adaptability to environmental change. This study explores the diversity of microorganisms associated with seafood. In this paper, we present our knowledge of microbial diversity in relation to seafood.
Christian Larbi Ayisi +3 more
wiley +1 more source
Botulinum toxin in ophthalmic plastic surgery
Indian Journal of Ophthalmology, 2005 Botulinum toxin chemodenervation has evolved greatly over the past 30 years since its introduction in the 1970s for the management of strabismus. Among ophthalmic plastic surgeons, botulinum toxins are often used as the first line treatment for facial ...
Naik Milind +3 more
doaj
JEADV Clinical Practice, EarlyView.ABSTRACT Background Residual limb hyperhidrosis (RLH) is a frequent and debilitating condition among lower‐limb prosthetic users. Although aluminium chloride is recommended first‐line for focal hyperhidrosis, its efficacy in RLH has not previously been evaluated in prospective studies.
Jette Schack +3 more
wiley +1 more source
Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip
Toxins, 2018 Botulinum neurotoxins (BoNTs), the etiological agents of botulism, are the deadliest toxins known to humans. Yet, thanks to their biological and toxicological features, BoNTs have become sophisticated tools to study neuronal physiology and valuable ...
Domenico Azarnia Tehran, Marco Pirazzini
doaj +1 more source
Botulinum toxin and spasticity [PDF]
Journal of Neurology, Neurosurgery & Psychiatry, 2000 The clinical effects of botulinum toxin have been recognised since the end of the 19th century. It is the most potent neurotoxin known and it is produced by the gram negative anaerobic bacterium Clostridium botulinum. The paralytic effect of the toxin is due to blockade of neuromuscular transmission.1 Injection into a muscle causes chemodenervation and
E C, Davis, M P, Barnes
openaire +2 more sources
Capsaicin protects neuromuscular junctions from the inhibitory effects of botulinum neurotoxin A [PDF]
, 2008 Within 24 hrs after injecting botulinum neurotoxin A (BoNT/A) into the hindlimb, mice lost the toe spread reflex and developed progressive muscle weakness. At the same time, the compound muscle action potential amplitude decreased. Injection of capsaicin
Carmen Garcia +5 more
core
Cervical Inlet Patches in R‐CPD: An Unrecognized Predictor of Treatment Failure
The Laryngoscope, EarlyView.This retrospective cohort study identified cervical inlet patches (CIP) in 19.8% of patients undergoing cricopharyngeal botulinum toxin injection for R‐CPD. CIP presence and increasing age independently predicted failure to sustain a long‐term treatment response, suggesting that CIP may be an underrecognized factor in R‐CPD treatment durability ...
Andrew Geoffrey Tritter +2 more
wiley +1 more source